2021 CNS Annual Meeting Accreditation
ACCME Accreditation Statement
The Congress of Neurological Surgeons is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement
The CNS designates this live activity for a maximum of 48 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
*A maximum of 25.50 AMA PRA Category 1 Credits™ may be earned for Scientific Sessions only.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Additional CME Credits can be earned by attending the following:
SYMPOSIA
Attendees will receive a maximum of 3.5 AMA PRA Category 1 Credits™ for each Saturday half-day Symposia, a maximum of 7 AMA PRA Category 1 Credits™ for each eligible Saturday full-day symposia.
Attendees will receive a maximum of 3.5 AMA PRA Category 1 Credits™ for each Sunday half-day Symposia, a maximum of 7 AMA PRA Category 1 Credits™ for each eligible Sunday full-day symposia.
LUNCHEON SEMINARS
Attendees will receive a maximum of one-and-a-half (1.5) AMA PRA Category 1 Credits™ for all eligible Luncheon Seminars.
DINNER SEMINARS
Attendees will receive a maximum of two (2) AMA PRA Category 1 Credits™ for all eligible Dinner Seminars.
INTERACTIVE MULTIMEDIA RESEARCH PRESENTATIONS
Physicians may claim a maximum of five (5) AMA PRA Category 1 Credits™ directly from the AMA for preparing a poster presentation, which is also included in the published abstracts. Physicians may claim them on their AMA PRA certificate application or apply directly to the AMA for an AMA PRA Category 1 Credits™ certificate.
*Physicians may claim AMA PRA Category 1 Credits™ for viewing scientific posters. Physicians should self claim credit on their AMA PRA certificate application form. Please visit the AMA website for details at https://www.ama-assn.org/
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures
View Disclosures
The Accreditation Council for Continuing Medical Education Standards for Commercial Support requires that anyone in a position to control the content of the educational activity has disclosed all financial relationships with any commercial interest. Failure or refusal to disclose or the inability to satisfactorily resolve the identified conflict may result in the withdrawal of the invitation to participate in any of the CNS educational activities. The ACCME defines a “commercial interest” as any entity producing, marketing, reselling, or distributing healthcare goods or services consumed by, or used on, patients. It is also each speaker’s responsibility to include the FDA clearance status of any device or drug requiring FDA approval discussed or described in their presentation or to describe the lack of FDA clearance for any “off label” uses discussed. Speakers from the audience are also required, therefore, to indicate any relevant personal/professional relationships as they discuss a given topic.
A listing of all Annual Meeting disclosures will be made available to meeting attendees.
CME and Evaluations
FDA Statement
Some drugs or medical devices demonstrated at the Annual Meeting have not been cleared by the FDA or have been cleared by the FDA for specific purposes only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or medical device he or she wishes to use in clinical practice. The CNS policy provides that “off label” uses of a drug or medical device may be described at the Annual Meeting so long as the “off label” use of the drug or medical device is also specifically disclosed. Any drug or medical device is “off label” if the described use is not set forth on the product’s approval label. It is also each speaker’s responsibility to include the FDA clearance status of any device or drug requiring FDA approval discussed or described in their presentation or to describe the lack of FDA clearance for any “off label” uses discussed. Speakers from the audience are also required, therefore, to indicate any relevant personal/professional relationships as they discuss a given topic.